Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling - Scorecard - MDSpire
Advertisement
Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling
Clinical Scorecard: Differential Regulation of CELA2A in the Stomach and Jejunum During Obesity and Post-Roux-en-Y Gastric Bypass Indicates Its Involvement in Gastrointestinal Metabolic Signaling
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients undergoing Roux-en-Y gastric bypass (RYGB) and other bariatric surgeries.
Care Setting
Key Highlights
Further studies needed to define CELA2A's cellular origin and functional role in metabolic signaling.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitoring changes in CELA2A levels post-surgery, focusing on specific time points and clinical outcomes.
Risks
Patient & Prescribing Data
RYGB leads to rapid improvements in glycemic control, potentially mediated by CELA2A; further research is needed to clarify this relationship.
Clinical Best Practices
Integrate CELA2A assessment in the evaluation of metabolic changes post-bariatric surgery, using specific assays and timelines.
